GenVec (GNVC) Says FDA Clinical Hold on CGF166 Phase 1/2 Lifted
Tweet Send to a Friend
GenVec, Inc. (Nasdaq: GNVC) announced that it was notified by its collaborator, Novartis, that the Food and Drug Administration (FDA) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE